Biocon shares rise after securing 10-year Pertuzumab supply contract in Brazil
Biocon Ltd. shares gained after the company secured a 10-year supply contract for Pertuzumab in Brazil. It signed a partnership agreement with Bahiafarma and Bionovis for the breast cancer treatment drug.